Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.
According to Cochlear Limited's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 11.49. At the end of 2023 the company had a P/B ratio of 8.62.
Year | P/B ratio |
---|---|
2024 | 11.49 |
2023 | 8.62 |
2022 | 7.75 |
2021 | 9.79 |
2020 | 7.78 |
2019 | 16.63 |
2018 | 18.81 |
2017 | 16.34 |
2016 | 15.39 |
2015 | 12.84 |
2014 | 10.66 |
2013 | 9.73 |
2012 | 9.68 |
2011 | 8.05 |
2010 | 9.47 |
2009 | 8.77 |
2008 | 7.48 |
2007 | 12.75 |
2006 | 14.28 |
2005 | 13.12 |
2004 | 8.65 |
2003 | 14.03 |
2002 | 23.48 |
2001 | 35.83 |
2000 | 33.91 |
1999 | 17.60 |
1998 | 9.76 |
1997 | 9.22 |
1996 | 8.94 |